Paper40779124
Nipocalimab: First Approval.
Fung S. Drugs, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Nipocalimab: First Approval. Papers, record 40779124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40779124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myasthenia Gravis | Major topic |
| Antibodies, Monoclonal, Humanized | Major topic |
| Humans | |
| Drug Approval | |
| Receptors, Fc | |
| United States | |
| Adult | |
| Child | |
| Histocompatibility Antigens Class I |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22882218 | Muscle autoantibodies in myasthenia gravis: beyond diagnosis? | Expert Rev Clin Immunol | 2012 | https://conductscience.org/library/papers/22882218 | PubMed |
| 2 | 38942592 | Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study. | RMD Open | 2024 | https://conductscience.org/library/papers/38942592 | PubMed |
| 3 | 39073504 | Pharmacokinetics and Pharmacodynamics of Nipocalimab, a Neonatal Fc Receptor Blocker, in Healthy Japanese Volunteers. | Clin Drug Investig | 2024 | https://conductscience.org/library/papers/39073504 | PubMed |
| 4 | 39115062 | Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn. | N Engl J Med | 2024 | https://conductscience.org/library/papers/39115062 | PubMed |
| 5 | 39862879 | Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study. | Lancet Neurol | 2025 | https://conductscience.org/library/papers/39862879 | PubMed |
| 6 | 30402880 | M281, an Anti-FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First-in-Human Study. | Clin Pharmacol Ther | 2019 | https://conductscience.org/library/papers/30402880 | PubMed |
| 7 | 38165333 | Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG Study | Neurology | 2024 | https://conductscience.org/library/papers/38165333 | PubMed |
| 8 | 39197469 | Design of a Phase 3, Global, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn. | Am J Perinatol | 2025 | https://conductscience.org/library/papers/39197469 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42921078 | Polyclonal IgG therapy in neurologic and neuromuscular disease: mechanisms of action and insights from newer therapies. | Front Neurol | 2026 | https://conductscience.org/library/papers/42921078 | PubMed |
| 42814271 | Rozanolixizumab: A Review in AChR or MuSK Autoantibody-Positive Generalised Myasthenia Gravis. | CNS Drugs | 2026 | https://conductscience.org/library/papers/42814271 | PubMed |
| 42041547 | Exosomes in Myasthenia Gravis-Review. | Cells | 2026 | https://conductscience.org/library/papers/42041547 | PubMed |
| 41807809 | A year in pharmacology: new drugs approved by the US food and drug administration in 2025. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41807809 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FCGRT | 2217 | PubTator's text mining | https://conductscience.org/library/genes/2217 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40779124
GET https://conductscience.org/api/papers/v1/40779124/authors